Hepatoprotective effects of semaglutide, lanifibranor and dietary intervention in the GAN diet-induced obese and biopsy-confirmed mouse model of NASH
Clinical and Translational Science 15(5):1167-1186, 2022
Integrative transcriptomic profiling of a mouse model of hypertension-accelerated diabetic kidney disease
Disease Models & Mechanisms 14(10): dmm049086, 2021
Empagliflozin improves metabolic and hepatic outcomes in a non-diabetic obese biopsy-proven mouse model of advanced NASH
International Journal of Molecular Sciences 22:6332, 2021
Comparative study of voxel-based statistical analysis methods for fluorescently labelled and light sheet imaged whole-brain samples
Proceedings of the 2021 IEEE 18th International Symposium on Biomedical Imaging, p. 1433-1437
Whole-brain mapping of amylin-induced neuronal activity in receptor activity–modifying protein (RAMP) 1/3 knockout mice
European Journal of Neuroscience 54:4154-4166, 2021
Elafibranor and liraglutide improve differentially liver health and metabolism in a mouse model of non-alcoholic steatohepatitis
Liver International 41(8):1853-1866, 2021